NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

Diabetologia

Volumn 40, Issue 11, 1997, Pages 1286-1292

  Pickup, J C ^a   Mattock, M B ^a   Chusney, G D ^a   Burt, D ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

acute phase response; cytokines; innate immune system; insulin resistance; interleukin 6; NIDDM; syndrome

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 6; OROSOMUCOID; SIALIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOLOGY; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYNDROME X;

ACUTE-PHASE PROTEINS; ADULT; ALBUMINURIA; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; OROSOMUCOID; SERUM AMYLOID A PROTEIN;

EID: 0030731621     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s001250050822     Document Type: Article

References (54)

1. 1. NM Kaplan 1989 The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension Arch Intern Med 149 1514 1520 2662932 10.1001/archinte.149.7.1514 1:CAS:528:DyaL1MXkslGmt7k%3D Kaplan NM (1989) The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149: 1514–1520
2. 2. BL Wajchenberg DA Malerbi MS Rocha AC Lerario ATMG Santomauro 1994 Syndrome X: a syndrome of insulin resistance Diabet Metab Rev 10 19 29 1:STN:280:DyaK2M%2FksVOlsw%3D%3D Wajchenberg BL, Malerbi DA, Rocha MS, Lerario AC, Santomauro ATMG (1994) Syndrome X: a syndrome of insulin resistance. Diabet Metab Rev 10: 19–29
3. 3. J Yudkin 1995 Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis J Intern Med 238 21 30 7608643 1:STN:280:DyaK2Mzjt1yhug%3D%3D 10.1111/j.1365-2796.1995.tb00895.x Yudkin J (1995) Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis. J Intern Med 238: 21–30
4. 4. GM Reaven 1988 Role of insulin resistance in human disease Diabetes 37 1595 1607 3056758 10.2337/diabetes.37.12.1595 1:STN:280:DyaL1M%2Flt12msQ%3D%3D Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
5. 5. I Zavaroni E Bonora M Pagliara 1989 Risk factors for coronary heart disease in healthy persons with hyperinsulinemia and normal glucose tolerance N Engl J Med 320 702 760 2646537 1:STN:280:DyaL1M7lvFejtg%3D%3D Zavaroni I, Bonora E, Pagliara M et al. (1989) Risk factors for coronary heart disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702–760
6. 6. OM Ganda CF Arkin 1992 Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes Diabetes Care 15 1245 1250 1425083 10.2337/diacare.15.10.1245 1:STN:280:DyaK3s%2FkvVGjsg%3D%3D Ganda OM, Arkin CF (1992) Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes. Diabetes Care 15: 1245–1250
7. 7. E Barrett-Connor 1992 Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus Ann Intern Med 117 807 811 1416554 1:STN:280:DyaK3s%2Fjs12hug%3D%3D Barrett-Connor E (1992) Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 117: 807–811
8. 8. M Crook P Tutt JC Pickup 1993 Elevated serum sialic acid concentration in non-insulin-dependent diabetes and its relationship to blood pressure and retinopathy Diabetes Care 16 57 60 8422833 10.2337/diacare.16.1.57 1:STN:280:DyaK3s7jslOjug%3D%3D Crook M, Tutt P, Pickup JC (1993) Elevated serum sialic acid concentration in non-insulin-dependent diabetes and its relationship to blood pressure and retinopathy. Diabetes Care 16: 57–60
9. 9. MA Crook P Tutt H Simpson JC Pickup 1993 Serum sialic acid and acute phase proteins in type 1 and 2 diabetes mellitus Clin Chim Acta 219 131 138 7508342 10.1016/0009-8981(93)90204-H 1:STN:280:DyaK2c7jvFSltg%3D%3D Crook MA, Tutt P, Simpson H, Pickup JC (1993) Serum sialic acid and acute phase proteins in type 1 and 2 diabetes mellitus. Clin Chim Acta 219: 131–138
10. 10. K Taniuchi K Chifu N Hayashi 1981 A new enzymatic method for the determination of sialic acid in serum and its application as a marker of acute phase reactants Kobe J Med Sci 27 91 102 7021999 1:CAS:528:DyaL3MXmtVSju7w%3D Taniuchi K, Chifu K, Hayashi N et al. (1981) A new enzymatic method for the determination of sialic acid in serum and its application as a marker of acute phase reactants. Kobe J Med Sci 27: 91–102
11. 11. A Rosenberg C-L Schengrund 1976 Circulating sialyl compounds A Rosenberg S Schengrund Biological roles of sialic acid Plenum New York 275 294 Rosenberg A, Schengrund C-L (1976) Circulating sialyl compounds. In: Rosenberg A, Schengrund S (eds) Biological roles of sialic acid. New York, Plenum pp 275–294
12. 12. JC Pickup MB Mattock MA Crook GD Chusney D Burt AP Fitzgerald 1995 Serum sialic acid concentration and coronary heart disease in NIDDM Diabetes Care 18 1100 1103 7587844 10.2337/diacare.18.8.1100 1:STN:280:DyaK28%2Fgt1Onuw%3D%3D Pickup JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP (1995) Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 18: 1100–1103
13. 13. VG Cabana JN Siegel SM Sabesin 1989 Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins J Lipid Res 30 39 49 2493057 1:CAS:528:DyaL1MXhsFahsrY%3D Cabana VG, Siegel JN, Sabesin SM (1989) Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 30: 39–49
14. 14. JD Blackman VG Cabana T Mazzone 1993 The acutephase response and associated lipoprotein abnormalities accompanying lymphoma J Intern Med 233 201 204 8433082 1:STN:280:DyaK3s7mtlOlsg%3D%3D Blackman JD, Cabana VG, Mazzone T(1993) The acutephase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med 233: 201–204
15. 15. RJ Spiegel EJ Schaefer IT Magrath B Edwards 1982 Plasma lipid alterations in leukemia and lymphoma Am J Med 72 775 782 7081275 10.1016/0002-9343(82)90543-5 1:STN:280:DyaL383gtlGhsg%3D%3D Spiegel RJ, Schaefer EJ, Magrath IT, Edwards B (1982) Plasma lipid alterations in leukemia and lymphoma. Am J Med 72: 775–782
16. 16. AG Olsson 1991 Non-atherosclerotic disease and lipoproteins Curr Opin Lipidol 2 206 210 10.1097/00041433-199106000-00009 1:CAS:528:DyaK38XkvVOmt7s%3D Olsson AG (1991) Non-atherosclerotic disease and lipoproteins. Curr Opin Lipidol 2: 206–210
17. 17. I Kushner A Mackiewicz 1993 The acute phase response: an overview A Mackiewicz I Kushner H Baumann Acute phase proteins: molecular biology, biochemistry and clinical applications CRC Press Boca Raton 3 19 Kushner I, Mackiewicz A (1993) The acute phase response: an overview. In: Mackiewicz A, Kushner I, Baumann H (eds) Acute phase proteins: molecular biology, biochemistry and clinical applications. CRC Press Boca Raton, pp 3–19
18. 18. DM Steel AS Whitehead 1994 The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A Immunol Today 15 81 87 8155266 10.1016/0167-5699(94)90138-4 1:CAS:528:DyaK2cXisVWru74%3D Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A. Immunol Today 15: 81–87
19. 19. RJ Jarrett GC Viberti A Argyropoulos RD Hill U Mahmud TJ Murreis 1984 Microalbuminuria predicts mortality in non-insulin-dependent diabetes Diabet Med 1 17 19 6242771 1:STN:280:DyaL2s3nsVKmtg%3D%3D Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murreis TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1: 17–19
20. 20. CE Mogensen 1984 Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310 356 360 6690964 1:STN:280:DyaL2c%2FptlGjtA%3D%3D Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360
21. 21. L Groop A Ekstrand C Forsblom 1993 Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 36 642 647 8359582 10.1007/BF00404074 1:STN:280:DyaK3szms1Siug%3D%3D Groop L, Ekstrand A, Forsblom C et al. (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 642–647
22. 22. MB Mattock H Keen GC Viberti 1988 Coronary heart disease and urinary albumin excretion in type 2 (non-insulin-dependent) diabetic patients Diabetologia 31 82 87 3360225 10.1007/BF00395552 1:STN:280:DyaL1c7ps1KltA%3D%3D Mattock MB, Keen H, Viberti GC et al. (1988) Coronary heart disease and urinary albumin excretion in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 82–87
23. 23. G Rose H Blackburn RF Gillum RJ Prineas 1982 Cardiovascular survey methods WHO Mongr Series 56 162 165 Rose G, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods. WHO Mongr Series 56 pp 162–165
24. 24. H Simpson GD Chusney MA Crook JC Pickup 1993 Serum sialic acid enzymatic assay based on microtitre plates Br J Biomed Sci 50 164 167 8219921 1:CAS:528:DyaK3sXms1Grsrw%3D Simpson H, Chusney GD, Crook MA, Pickup JC (1993) Serum sialic acid enzymatic assay based on microtitre plates. Br J Biomed Sci 50: 164–167
25. 25. H Keen C Clouverakis 1963 An immunoassay for urinary albumin at low concentration Lancet ii 913 916 10.1016/S0140-6736(63)90620-2 Keen H, Clouverakis C (1963) An immunoassay for urinary albumin at low concentration. Lancet ii: 913–916
26. 26. RJ Havel HA Eden JH Bragdon 1955 The distribution and chemical composition of ultracentrifugationally separated lipoproteins in human serum J Clin Invest 34 1345 1353 13252080 10.1172/JCI103182 1:CAS:528:DyaG28XitFyn Havel RJ, Eden HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugationally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
27. 27. A Jonsson JK Wales 1976 Blood glycoprotein levels in diabetes mellitus Diabetologia 12 245 250 60265 10.1007/BF00422091 1:STN:280:DyaE283lvVerug%3D%3D Jonsson A, Wales JK (1976) Blood glycoprotein levels in diabetes mellitus. Diabetologia 12: 245–250
28. 28. DE McMillan 1989 Increased levels of acute-phase serum proteins in diabetes Metabolism 38 1042 1046 2478861 10.1016/0026-0495(89)90038-3 1:STN:280:DyaK3c%2FktlaisA%3D%3D McMillan DE (1989) Increased levels of acute-phase serum proteins in diabetes. Metabolism 38: 1042–1046
29. 29. KR Feingold I Staprans RA Memon 1992 Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance J Lipid Res 33 1765 1776 1479286 1:CAS:528:DyaK3sXltl2mtQ%3D%3D Feingold KR, Staprans I, Memon RA et al. (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33: 1765–1776
30. 30. R Kisilevsky 1991 Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism Med Hypoth 35 337 341 10.1016/0306-9877(91)90280-C 1:CAS:528:DyaK3MXmt1yqsLY%3D Kisilevsky R (1991) Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism. Med Hypoth 35: 337–341
31. 31. H Baumann J Gauldie 1994 The acute phase response Immunol Today 15 74 80 7512342 10.1016/0167-5699(94)90137-6 1:CAS:528:DyaK2cXisVWrurc%3D Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15: 74–80
32. 32. CA Dinarello 1991 Interleukin-1 AW Thomson The cytokine handbook Academic Press London 47 82 Dinarello CA (1991) Interleukin-1. In: Thomson AW (ed) The cytokine handbook. Academic Press London, pp 47–82
33. 33. S Akira T Taga T Kishimoto 1993 Interleukin-6 in biology and medicine Adv Immunol 54 1 78 8379461 10.1016/S0065-2776(08)60532-5 1:CAS:528:DyaK3sXms1yitLY%3D Akira S, Taga T, Kishimoto T (1993) Interleukin-6 in biology and medicine. Adv Immunol 54: 1–78
34. 34. M Jaattela 1991 Biological activities and mechanisms of action of tumor necrosis factor α/cachectin Lab Invest 64 724 742 1646350 1:CAS:528:DyaK3MXmsFentLw%3D Jaattela M (1991) Biological activities and mechanisms of action of tumor necrosis factor α/cachectin. Lab Invest 64: 724–742
35. 35. C Rivier W Vale 1984 Influence of corticotrophin-releasing factor on reproductive functions in the rat Endocrinology 114 914 921 6321146 1:CAS:528:DyaL2cXhtlaqs7g%3D Rivier C, Vale W (1984) Influence of corticotrophin-releasing factor on reproductive functions in the rat. Endocrinology 114: 914–921
36. 36. DN Brindley 1992 Neuroendocrine regulation and obesity Int J Obes 16 3 73 79 Brindley DN (1992) Neuroendocrine regulation and obesity. Int J Obes 16 [Suppl 3]: 73–79
37. 37. P Björntorp 1992 Biochemistry of obesity in relation to diabetes KGMM Alberti RA DeFronzo H Keen P Zimmet International textbook of diabetes John Wiley Chichester 551 568 Björntorp P (1992) Biochemistry of obesity in relation to diabetes. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) International textbook of diabetes. John Wiley Chichester pp 551–568
38. 38. B Jeanrenaud 1995 Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint Diabetologia 38 998 1002 7589889 10.1007/BF00400592 1:CAS:528:DyaK2MXnsFyitLk%3D Jeanrenaud B (1995) Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint. Diabetologia 38: 998–1002
39. 39. A Figueredo JL Ibarra J Bagazgoitia 1993 Plasma C3d levels and ischemic heart disease in type II diabetes Diabetes Care 16 445 449 8432215 10.2337/diacare.16.2.445 1:STN:280:DyaK3s7mtFyrug%3D%3D Figueredo A, Ibarra JL, Bagazgoitia J et al. (1993) Plasma C3d levels and ischemic heart disease in type II diabetes. Diabetes Care 16: 445–449
40. 40. KR Feingold C Grunfeld 1992 Role of cytokines in inducing hyperlipidemia Diabetes 41 2 97 101 1526345 1:CAS:528:DyaK3sXitVCmtw%3D%3D Feingold KR, Grunfeld C (1992) Role of cytokines in inducing hyperlipidemia. Diabetes 41: [Suppl 2] 97–101
41. 41. T Yokota GK Hansson 1995 Immunological mechanisms in atherosclerosis J Intern Med 238 479 489 9422033 1:STN:280:DyaK1c%2Fotl2msw%3D%3D Yokota T, Hansson GK (1995) Immunological mechanisms in atherosclerosis. J Intern Med 238: 479–489
42. 42. GS Hotamisligil BM Spiegelman 1994 Tumor necrosis factor a: a key component of the obesity-diabetes link Diabetes 43 1271 1278 7926300 10.2337/diabetes.43.11.1271 1:CAS:528:DyaK2cXmslOltro%3D Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes 43: 1271–1278
43. 43. K Bendtzen K Buschard M Diamant T Horn M Svenson 1989 Possible role of IL-1, TNFα and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease Lymphokine Res 8 335 341 2674559 1:CAS:528:DyaL1MXltlags7c%3D Bendtzen K, Buschard K, Diamant M, Horn T, Svenson M (1989) Possible role of IL-1, TNFα and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Lymphokine Res 8: 335–341
44. 44. A Rabinovitch 1994 Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM Diabetes 43 613 621 8168635 10.2337/diabetes.43.5.613 1:CAS:528:DyaK2cXktlaqtb8%3D Rabinovitch A (1994) Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43: 613–621
45. 45. JC Pickup CD Day C Bailey 1995 Plasma sialic acid in animal models of diabetes mellitus: evidence for modulation of sialic acid concentrations by insulin deficiency Life Sci 57 1383 1391 7564886 10.1016/0024-3205(95)02096-2 1:CAS:528:DyaK2MXnslOlsLs%3D Pickup JC, Day CD, Bailey C et al. (1995) Plasma sialic acid in animal models of diabetes mellitus: evidence for modulation of sialic acid concentrations by insulin deficiency. Life Sci 57: 1383–1391
46. 46. D Thompson SP Harrison SW Evans JT Whicher 1991 Insulin modulation of acute-phase protein production in a human hepatoma cell line Cytokine 3 619 626 1724187 10.1016/1043-4666(91)90489-Z 1:CAS:528:DyaK38Xht1Kht7o%3D Thompson D, Harrison SP, Evans SW, Whicher JT (1991) Insulin modulation of acute-phase protein production in a human hepatoma cell line. Cytokine 3: 619–626
47. 47. SP Campos H Baumann 1992 Insulin is a prominent modulator of the cytokine-stimulated expression of acutephase plasma protein genes Mol Cell Biol 12 1789 1797 1372389 1:CAS:528:DyaK38XitVyiu70%3D Campos SP, Baumann H (1992) Insulin is a prominent modulator of the cytokine-stimulated expression of acutephase plasma protein genes. Mol Cell Biol 12: 1789–1797
48. 48. J Stuart AJ George AJ Davies A Aukland RA Hurlow 1981 Haematological stress syndrome in atherosclerosis J Clin Pathol 34 464 467 7251888 10.1136/jcp.34.5.464 1:STN:280:DyaL3M3ktVWluw%3D%3D Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA (1981) Haematological stress syndrome in atherosclerosis. J Clin Pathol 34: 464–467
49. 49. MA Mendall P Patel L Ballam D Strachan TC Northfield 1996 C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study Br Med J 312 1061 1065 1:STN:280:DyaK283gs1yntQ%3D%3D Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC (1996) C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 312: 1061–1065
50. 50. H Vlassara M Brownlee KR Manogue C Dinarello A Pasagian 1988 Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue modelling Science 240 1546 1548 3259727 10.1126/science.3259727 1:CAS:528:DyaL1cXktlKgtLs%3D Vlassara H, Brownlee M, Manogue KR, Dinarello C, Pasagian A (1988) Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue modelling. Science 240: 1546–1548
51. 51. F Imani Y Horii M Suthanthiran 1993 Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon y: role in tissue remodelling J Exp Med 178 2165 2172 8245789 10.1084/jem.178.6.2165 1:CAS:528:DyaK3sXmt1equro%3D Imani F, Horii Y, Suthanthiran M et al. (1993) Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon y: role in tissue remodelling. J Exp Med 178: 2165–2172
52. 52. DJP Barker CN Hales CHD Fall C Osmond K Phipps PMS Clark 1993 Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth Diabetologia 36 62 67 8436255 10.1007/BF00399095 1:STN:280:DyaK3s7ntVKjuw%3D%3D Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62–67
53. 53. M Caswell LA Pike BS Bull J Stuart 1993 Effect of age on tests of the acute-phase response Arch Pathol Lab Med 117 906 910 7690224 1:STN:280:DyaK3sznvVGisQ%3D%3D Caswell M, Pike LA, Bull BS, Stuart J (1993) Effect of age on tests of the acute-phase response. Arch Pathol Lab Med 117: 906–910
54. 54. U Fagiolo A Cossarizza E Scala 1993 Increased cytokine production in mononuclear cells of healthy elderly people Eur J Immunol 23 2375 2378 8370415 10.1002/eji.1830230950 1:CAS:528:DyaK3sXms1yltrk%3D Fagiolo U, Cossarizza A, Scala E et al. (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375–2378